GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AcouSort AB (OSTO:ACOU) » Definitions » EV-to-FCF

AcouSort AB (OSTO:ACOU) EV-to-FCF : -8.84 (As of Jun. 03, 2024)


View and export this data going back to 2020. Start your Free Trial

What is AcouSort AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, AcouSort AB's Enterprise Value is kr175.61 Mil. AcouSort AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was kr-19.87 Mil. Therefore, AcouSort AB's EV-to-FCF for today is -8.84.

The historical rank and industry rank for AcouSort AB's EV-to-FCF or its related term are showing as below:

OSTO:ACOU' s EV-to-FCF Range Over the Past 10 Years
Min: -38.58   Med: -18.49   Max: 65.51
Current: -8.69

During the past 11 years, the highest EV-to-FCF of AcouSort AB was 65.51. The lowest was -38.58. And the median was -18.49.

OSTO:ACOU's EV-to-FCF is ranked worse than
100% of 378 companies
in the Biotechnology industry
Industry Median: 8.345 vs OSTO:ACOU: -8.69

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-03), AcouSort AB's stock price is kr13.15. AcouSort AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr-1.271. Therefore, AcouSort AB's PE Ratio for today is At Loss.


AcouSort AB EV-to-FCF Historical Data

The historical data trend for AcouSort AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AcouSort AB EV-to-FCF Chart

AcouSort AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -30.54 -24.90 54.76 -6.36

AcouSort AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.82 -16.34 -25.89 -6.36 -8.22

Competitive Comparison of AcouSort AB's EV-to-FCF

For the Biotechnology subindustry, AcouSort AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AcouSort AB's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AcouSort AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where AcouSort AB's EV-to-FCF falls into.



AcouSort AB EV-to-FCF Calculation

AcouSort AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=175.610/-19.868
=-8.84

AcouSort AB's current Enterprise Value is kr175.61 Mil.
AcouSort AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-19.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AcouSort AB  (OSTO:ACOU) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

AcouSort AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=13.15/-1.271
=At Loss

AcouSort AB's share price for today is kr13.15.
AcouSort AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.271.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


AcouSort AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of AcouSort AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


AcouSort AB (OSTO:ACOU) Business Description

Traded in Other Exchanges
Address
Medicon Village, Lund, SWE, SE-223 81
AcouSort AB is a company that specializes in products and solutions for the automated preparation of biological samples for researchers and life science companies. Its technology is based on using ultrasound to isolate, separate or trap microscopic particles such as blood cells, bacteria, or extracellular vesicles in microfluidic channels. The company products include AcouTrap, AcouWash, and AcouPlasma.

AcouSort AB (OSTO:ACOU) Headlines

No Headlines